Interestingly, we found that these molecules increased in GBM cells treated with NAC, a ROS scavenger, suggesting that the SH3GL3/DNM3-EMT axis may be regulated by additional unknown factors that may function in ROS-dependent pathways (Supplementary Fig. 10a, b). The gene discussed is DNM3; the disease is glioblastoma.